Wang, Zhijie <br/><br/>
Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer-Reply.  [electronic resource] 

 -  JAMA oncology  07 2020 
 - 1116-1117 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>2374-2445 
<br/><br/><label>Standard No.: </label>10.1001/jamaoncol.2020.0646  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>B7-H1 Antigen<br/>Humans<br/>Immune Checkpoint Inhibitors<br/>Immunotherapy<br/>Ligands<br/>Neoplasms--drug therapy